Show simple item record

dc.contributor.authorChiappini, Stephania
dc.contributor.authorGuirguis, Amira
dc.contributor.authorCorkery, John
dc.contributor.authorSchifano, Fabrizio
dc.date.accessioned2020-11-23T10:30:02Z
dc.date.available2020-11-23T10:30:02Z
dc.date.issued2020-11-18
dc.identifier.citationChiappini , S , Guirguis , A , Corkery , J & Schifano , F 2020 , ' Understanding the use of prescription and OTC drugs in obtaining illicit highs and the pharmacist role in preventing abuse ' , The Pharmaceutical Journal , vol. 305 , no. 7943 . https://doi.org/10.1211/PJ.2020.20208538
dc.identifier.issn0031-6873
dc.identifier.otherPURE: 23026948
dc.identifier.otherPURE UUID: c6f6bb68-f9f2-46c9-9b3d-544eadb82d6c
dc.identifier.urihttp://hdl.handle.net/2299/23497
dc.descriptionThis is accepted text of Understanding the use of prescription and OTC drugs in obtaining illicit highs and the pharmacist role in preventing abuse. The Pharmaceutical Journal, Vol 305, No 7943, online | DOI: 10.1211/PJ.2020.20208538
dc.description.abstractThere have been increasing reports of misuse of a range of prescription and over-the-counter (OTC) drugs for recreational purposes. The use of psychoactive pharmaceuticals and ‘pharming’ are new, widespread phenomena involving the non-medical use of prescription and OTC drugs, which are recreationally used to achieve psychoactive effects either on their own or in combination with other substances. This article provides an overview of the topic, focusing on a range of medicines (e.g. prescription medicines such as quetiapine, gabapentinoids, Z-drugs, bupropion, venlafaxine, and over-the-counter medicines such as loperamide, dextromethorphan, benzydamine, promethazine, chlorphenamine, diphenhydramine and hyoscine butylbromide) that have emerged as misused and diverted, or already described through the literature, as well as recorded by drug users’ online websites reporting new trends and experimentations of drug abuse. This rapidly changing drug scenario represents a challenge for pharmacy, psychiatry, public health and drug control policies. Moreover, possibly resulting from the COVID-19 pandemic, drug use-habits and availability have changed, causing a shift in behaviours relating to both prescription and OTC medicines. Healthcare professionals should be aware of potential prescription drugs diversion, recognise misuse cases, consider the possibility of polydrug misuse, and prevent it where possible. Pharmacists can play a key role in preventing and reducing drug abuse and should be involved in evidence-based actions to detect, understand and prevent drug diversion activities and the adverse effects of drug-misuse.en
dc.format.extent31
dc.language.isoeng
dc.relation.ispartofThe Pharmaceutical Journal
dc.subjectdrug abuse
dc.subjectprescription drug misuse
dc.subjectover-the-counter drug abuse
dc.subjectnovel psychoactive substances (NPS)
dc.subjectpharmacovigilance
dc.titleUnderstanding the use of prescription and OTC drugs in obtaining illicit highs and the pharmacist role in preventing abuseen
dc.contributor.institutionDepartment of Clinical and Pharmaceutical Sciences
dc.contributor.institutionCentre for Health Services and Clinical Research
dc.contributor.institutionPsychopharmacology, Drug Misuse and Novel Psychoactive Substances Unit
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionDepartment of Clinical, Pharmaceutical and Biological Science
dc.description.statusPeer reviewed
rioxxterms.versionAM
rioxxterms.versionofrecordhttps://doi.org/10.1211/PJ.2020.20208538
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record